Clinical trial
A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects
NCT00454233 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00454233 |
|---|---|
| Title | A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects |
| Official title | A Randomized, Double Blind, Placebo and Active Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Potential Efficacy of a 12-Week Treatment With YM543 in Subjects With Type 2 Diabetes Mellitus |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2 |
| Intervention type | Drug |
| Interventions | YM543, Metformin, Placebo |
| Enrollment | 97 |
| Start date | Feb 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Mar 30, 2007 |
| Last update posted | Oct 16, 2008 |
| Countries | Russia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: